miltefosine has been researched along with pentamidine in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (21.57) | 29.6817 |
2010's | 35 (68.63) | 24.3611 |
2020's | 5 (9.80) | 2.80 |
Authors | Studies |
---|---|
Boykin, DW; Brun, R; Salem, MM; Stephens, CE; Tanious, F; Werbovetz, KA; Wilson, WD | 1 |
Goyal, N; Gupta, S; Pandey, S; Suryawanshi, SN | 1 |
Delfín, DA; Morgan, RE; Werbovetz, KA; Zhu, X | 1 |
Bisht, SS; Gupta, S; Kumar, A; Mishra, M; Mittal, M; Pandey, VP; Sane, SA; Siddiqi, MI; Tripathi, RP; Verma, A | 1 |
Boykin, DW; Hall, JE; Kyle, DE; Liu, Q; Madhubala, R; Mandal, S; Munde, M; Pandharkar, T; Parman, T; Riccio, E; Srivastava, A; Stephens, CE; Sweat, JM; Tidwell, RR; Wang, MZ; Werbovetz, KA; Wilson, WD; Zhu, X | 1 |
Baumann, K; Bischof, SK; Bringmann, G; Brun, R; Dreher, J; Gulder, T; Kaiser, M; Moll, H; Müller, S; Stich, A; Winter, C | 1 |
Carvalho, L; Castanys, S; Gamarro, F; Manzano, JI; Pérez-Victoria, JM | 1 |
Alami, M; Audisio, D; Bories, C; Brion, JD; Cojean, S; Huteau, F; Loiseau, PM; Messaoudi, S; Peyrat, JF | 1 |
Azas, N; Casanova, M; Castera-Ducros, C; Dumètre, A; Hutter, S; Kraiem-M'rabet, M; Laget, M; Mbatchi, L; Paloque, L; Rathelot, P; Rault, S; Remusat, V; Vanelle, P; Verhaeghe, P | 1 |
Chan, KF; Chan, TH; Chow, LM; Wong, IL | 1 |
Chauhan, PM; Gupta, S; Khan, S; Kidwai, S; Puri, SK; Shivahare, R; Srivastava, K; Tyagi, V | 1 |
Buisson, D; Fromentin, Y; Gaboriaud-Kolar, N; Grellier, P; Lallemand, MC; Lenta, BN; Loiseau, PM; Michel, S; Mouray, E; Wansi, JD | 1 |
Arafa, RK; Boykin, DW; Brun, R; Ismail, MA; Jones, SK; Pandharkar, T; Patrick, DA; Tidwell, RR; Wenzler, T; Werbovetz, KA; Zhu, X | 1 |
Abada, Z; Akagah, B; Cojean, S; Ferrié, L; Figadère, B; Loiseau, PM; Lormier, AT; Pomel, S | 1 |
Brun, R; Harel, D; Prinz, H; Schepmann, D; Schmidt, TJ; Wünsch, B | 1 |
Azas, N; Cantelli, C; Casanova, M; Castera-Ducros, C; Cohen, A; Crozet, MD; Hutter, S; Laget, M; Paloque, L; Rathelot, P; Remusat, V; Tanguy, F; Vanelle, P; Verhaeghe, P | 1 |
Chauhan, K; Chauhan, PM; Debnath, U; Gupta, S; Prabhakar, YS; Sharma, M; Shivahare, R | 1 |
Avery, VM; Baell, JB; Bergström, CA; Charman, SA; Ferrins, L; Gazdik, M; Jones, AJ; Kaiser, M; Rahmani, R; Ryan, E; Sykes, ML; Varghese, S; White, KL | 1 |
Blonski, C; Djilali, R; Jagu, E; Labruère, R; Loiseau, PM; Pethe, S; Pomel, S; Ramiandrasoa, F | 1 |
Azas, N; Castera-Ducros, C; Cohen, A; Hutter, S; Kieffer, C; Laget, M; M'Rabet, MK; Rathelot, P; Rault, S; Remusat, V; Vanelle, P; Verhaeghe, P | 1 |
Azas, N; Castera-Ducros, C; Cohen, A; Hutter, S; Kieffer, C; Laget, M; Paloque, L; Rathelot, P; Rault, S; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Alexandre-Moreira, MS; da Matta, CB; DaCosta, JB; de Queiroz, AC; Del Cistia, Cde N; Gonçalves, VT; Sant'Anna, CM; Santos, MS | 1 |
Bosc, D; Cojean, S; Dubois, J; Franco, CH; Freitas-Junior, LH; Grellier, P; Loiseau, PM; Moraes, CB; Mouray, E | 1 |
Alunda, JM; Baptista, C; Behrens, B; Bifeld, E; Borsari, C; Clos, J; Cordeiro-da-Silva, A; Corral, MJ; Costantino, L; Costi, MP; Dello Iacono, L; Di Pisa, F; Eick, J; Ellinger, B; Ferrari, S; Gribbon, P; Gul, S; Henrich, S; Jiménez-Antón, MD; Keminer, O; Kohler, M; Kuzikov, M; Landi, G; Luciani, R; Mangani, S; Pellati, F; Poehner, I; Pozzi, C; Reinshagen, J; Santarem, N; Tait, A; Tejera Nevado, P; Torrado, J; Trande, M; Wade, RC; Witt, G; Wolf, M | 1 |
Blonski, C; Diez-Martinez, A; Jagu, E; Krauth-Siegel, RL; Labruère, R; Loiseau, PM; Pethe, S; Pomel, S; Ramiandrasoa, F | 1 |
Alcântara, LM; Alunda, JM; Baptista, C; Bertolacini, CD; Borsari, C; Bruno Dos Santos, P; Clos, J; Cordeiro-da-Silva, A; Corral, MJ; Costantino, L; Costi, MP; Ellinger, B; Ferrari, S; Fontana, V; Franco, CH; Freitas-Junior, LH; Gribbon, P; Gul, S; Kuzikov, M; Linciano, P; Moraes, CB; Olías, AI; Reinshagen, J; Santarem, N; Tait, A; Tejera Nevado, P; Torrado, J; Witt, G; Wolf, M | 1 |
Argüello-Garcia, R; Barbosa-Cabrera, E; Chan-Bacab, MJ; Colín-Lozano, B; Hernández-Núñez, E; León-Rivera, I; López-Guerrero, V; Moo-Puc, R; Navarrete-Vázquez, G; Ortega-Morales, BO; Scior, T | 1 |
Alcantara, LM; Cordeiro-da-Silva, A; Costantino, L; Costi, MP; Ellinger, B; Ferrari, S; Franco, CH; Freitas-Junior, LH; Gul, S; Kuzikov, M; Linciano, P; Luciani, R; Macedo, S; Moraes, CB; Pascoalino, B; Quotadamo, A; Santarem, N; Witt, G | 1 |
Ashok, P; Chander, S; Sankaranarayanan, M; Smith, TK | 1 |
Cantizani, J; Cogo, J; Corrêa, AG; Cotillo, I; Filho, BPD; Martín, JJ; Nakamura, CV; Sangi, DP; Ueda-Nakamura, T | 1 |
Azas, N; Basmaciyan, L; Belle Mbou, V; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, É; Casanova, M; Castera-Ducros, C; Cohen, A; Courtioux, B; Fairlamb, AH; Fersing, C; Hutter, S; Laget, M; Milne, R; Pedron, J; Piednoel, M; Primas, N; Rathelot, P; Since, M; Sournia-Saquet, A; Valentin, A; Vanelle, P; Verhaeghe, P; Wyllie, S | 1 |
Baptista, C; Bonucci, A; Cordeiro-da-Silva, A; Costantino, L; Costi, MP; di Pisa, F; Ellinger, B; Ferrari, S; Franco, C; Gul, S; Iacono, LD; Kuzikov, M; Landi, G; Linciano, P; Luciani, R; Mangani, S; Moraes, CB; Müller, W; Pöhner, I; Pozzi, C; Quotadamo, A; Santarem, N; Sesenna, A; Witt, G; Wittig, U | 1 |
Bhatia, R; Gupta, O; Monga, V; Pradhan, T | 1 |
Carvalho, C; Cordeiro da Silva, A; Duarte, D; Kijjoa, A; Long, S; Moreira, R; Nogueira, F; Oliveira, R; Palmeira, A; Pinto, MMM; Resende, DISP; Santarém, N; Silva, AMS; Sousa, E | 1 |
Carvalho, MA; Cordeiro-da-Silva, A; Lopes, A; Santarém, N | 1 |
Sundar, S | 1 |
Berman, J | 1 |
Singh, S; Sivakumar, R | 1 |
Kumar, A; Sundar, S | 1 |
Bandyopadhyay, S; Chatterjee, M; Ganguly, S; Sarkar, A | 1 |
Minodier, P; Parola, P | 1 |
Acquaviva, V; Antinori, S; Bestetti, G; Corbellino, M; Foschi, A; Longhi, E; Meroni, L; Parravicini, C; Piolini, R; Trovati, S | 1 |
Chatterjee, M; Mandal, G; Sarkar, A; Singh, N; Sundar, S | 1 |
Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
Kumar, M; Singh, N; Singh, RK | 1 |
Chirouze, C; Faucher, JF; Hoen, B; Le Moing, V; Morquin, D; Reynes, J | 1 |
de Paula, E; Giorgio, S; Ortega, V | 1 |
Calderón-Gomezcaseres, Á; Rodriguez-Morales, AJ; Villamil-Gómez, WE | 1 |
Alexandre-Moreira, MS; Alves, MA; Barreiro, EJ; Cavalcanti de Queiroz, A; Lima, LM | 1 |
Bano, S; Bibi, M; Choudhary, MI; Farooq, S; Khoso, BK; Shaikh, M; Yousuf, S; Zafar, H | 1 |
Kazemirad, E; Latifi, A; Mohebali, M; Rezaian, M; Soleimani, M; Yasami, S | 1 |
7 review(s) available for miltefosine and pentamidine
Article | Year |
---|---|
Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships.
Topics: Animals; Cell Line, Tumor; Heterocyclic Compounds; Humans; Leishmania; Leishmaniasis; Molecular Structure; Small Molecule Libraries; Structure-Activity Relationship; Trypanocidal Agents | 2021 |
Current treatment approaches to leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine | 2003 |
Challenges and new discoveries in the treatment of leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania; Leishmaniasis; Pentamidine; Phosphorylcholine; Psychodidae | 2004 |
Cutaneous leishmaniasis treatment.
Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Humans; Imiquimod; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Paromomycin; Pentamidine; Phosphorylcholine | 2007 |
Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Americas; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Asia; Humans; Italy; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Middle Aged; Pentamidine; Phosphorylcholine; Travel | 2007 |
Leishmaniasis: current status of available drugs and new potential drug targets.
Topics: Aminoquinolines; Amphotericin B; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Caspase Inhibitors; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Leishmaniasis; Macrophages; Microbodies; Mitogen-Activated Protein Kinase Kinases; Paromomycin; Pentamidine; Phosphorylcholine; Polyamines; Protease Inhibitors; Sterols; Sulfhydryl Compounds; Topoisomerase Inhibitors | 2012 |
Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Leishmaniasis; Liposomes; Nanoparticles; Paromomycin; Particle Size; Pentamidine; Phosphorylcholine; Surface Properties | 2017 |
44 other study(ies) available for miltefosine and pentamidine
Article | Year |
---|---|
The activity of diguanidino and 'reversed' diamidino 2,5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani.
Topics: Amidines; Animals; DNA; Furans; Guanidine; Inhibitory Concentration 50; Leishmania donovani; Macrophages; Nucleic Acid Denaturation; Oligodeoxyribonucleotides; Poly dA-dT; Protozoan Proteins; Structure-Activity Relationship; Temperature; Trypanocidal Agents; Trypanosoma cruzi | 2003 |
Chemotherapy of leishmaniasis. Part V: Synthesis and in vitro bioevaluation of novel pyridinone derivatives.
Topics: Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmaniasis; Pyridones | 2007 |
Redox-active dinitrodiphenylthioethers against Leishmania: synthesis, structure-activity relationships and mechanism of action studies.
Topics: Animals; Antiprotozoal Agents; Chlorocebus aethiops; Leishmania donovani; Macrophages, Peritoneal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred Strains; Oxidation-Reduction; Quantitative Structure-Activity Relationship; Reactive Oxygen Species; Sulfides; Vero Cells | 2009 |
Synthesis and molecular docking studies of 1-phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agents.
Topics: Animals; Antiprotozoal Agents; Cell Line; Leishmania donovani; Life Cycle Stages; Mice; Models, Molecular; Molecular Conformation; Oxidoreductases; Pyridines | 2010 |
Novel arylimidamides for treatment of visceral leishmaniasis.
Topics: Amidines; Animals; Antiprotozoal Agents; Biological Availability; Cricetinae; Disease Models, Animal; Drug Discovery; Female; Furans; Humans; In Vitro Techniques; Leishmania donovani; Leishmania major; Leishmania mexicana; Leishmaniasis, Visceral; Liver; Mesocricetus; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mutagenicity Tests; Parasitemia; Parasitic Sensitivity Tests; Spleen; Tissue Distribution | 2010 |
QSAR guided synthesis of simplified antiplasmodial analogs of naphthylisoquinoline alkaloids.
Topics: Alkaloids; Animals; Antimalarials; Isoquinolines; Magnetic Resonance Spectroscopy; Models, Molecular; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared | 2010 |
Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major.
Topics: Adenosine Triphosphate; Aminoquinolines; Antiprotozoal Agents; Drug Resistance; Glycolysis; Leishmania major; Pyruvate Kinase | 2011 |
Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.
Topics: Animals; Antiprotozoal Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Leishmania donovani; Mice; Quinolones; Structure-Activity Relationship; Trypanosoma brucei brucei | 2012 |
Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Hep G2 Cells; Humans; Leishmania donovani; Life Cycle Stages; Mice; Nitroquinolines | 2012 |
Flavonoid dimers as novel, potent antileishmanial agents.
Topics: Amines; Animals; Antiprotozoal Agents; Cell Line; Dimerization; Drug Resistance; Flavonoids; Leishmania; Macrophages, Peritoneal; Mice; Polyethylene Glycols; Structure-Activity Relationship | 2012 |
A natural product inspired hybrid approach towards the synthesis of novel pentamidine based scaffolds as potential anti-parasitic agents.
Topics: Antimalarials; Antiprotozoal Agents; Biological Products; Chalcone; Pentamidine; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship | 2013 |
Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani.
Topics: Antiprotozoal Agents; Benzophenones; Clusiaceae; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Seeds; Structure-Activity Relationship; Trypanosoma brucei brucei | 2013 |
Synthesis and antiprotozoal activity of dicationic m-terphenyl and 1,3-dipyridylbenzene derivatives.
Topics: Animals; Antiprotozoal Agents; Benzene; Chagas Disease; Female; Leishmania donovani; Mice; Mice, Inbred Strains; Models, Chemical; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridines; Structure-Activity Relationship; Terphenyl Compounds; Trypanosoma cruzi | 2013 |
Synthesis and antiprotozoal activity of original porphyrin precursors and derivatives.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium; Porphyrins; Structure-Activity Relationship; Trypanosoma brucei brucei | 2013 |
Natural product derived antiprotozoal agents: synthesis, biological evaluation, and structure-activity relationships of novel chromene and chromane derivatives.
Topics: Antiprotozoal Agents; Biological Products; Chemistry Techniques, Synthetic; Chromans; Inhibitory Concentration 50; Structure-Activity Relationship | 2013 |
Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
Topics: Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Imidazoles; Leishmania donovani; Mice; Pyridines; Structure-Activity Relationship | 2013 |
Discovery of triazine mimetics as potent antileishmanial agents.
Topics: | 2013 |
Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
Topics: Animals; Benzamides; Cell Line; HEK293 Cells; Humans; Microsomes, Liver; Myoblasts; Pyridines; Rats; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense | 2014 |
Design, synthesis and in vitro antikinetoplastid evaluation of N-acylated putrescine, spermidine and spermine derivatives.
Topics: Acylation; Antiprotozoal Agents; Drug Design; Drug Evaluation, Preclinical; Kinetoplastida; Leishmania donovani; Putrescine; Spermidine; Spermine; Trypanosoma brucei brucei | 2015 |
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Nitroquinolines; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2015 |
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Topics: Antiprotozoal Agents; Drug Design; Hep G2 Cells; Humans; Leishmania donovani; Leishmania infantum; Life Cycle Stages; Macrophages; Nitroquinolines; Parasitic Sensitivity Tests; Pentamidine; Phosphorylcholine; Structure-Activity Relationship | 2015 |
Novel dialkylphosphorylhydrazones: Synthesis, leishmanicidal evaluation and theoretical investigation of the proposed mechanism of action.
Topics: Animals; Dose-Response Relationship, Drug; Hexokinase; Hydrazones; Leishmania; Macrophages; Mice; Molecular Docking Simulation; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents | 2015 |
Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.
Topics: Alkyl and Aryl Transferases; Animals; Antiparasitic Agents; Cell Line; Enzyme Inhibitors; Humans; Imidazoles; Leishmania donovani; Leishmaniasis, Visceral; Malaria, Falciparum; Mice; Parasitic Sensitivity Tests; Plasmodium falciparum; Trypanosoma; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis | 2016 |
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
Topics: Animals; Biological Products; Cell Line; Dose-Response Relationship, Drug; Flavonols; Humans; Macrophages; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2016 |
Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Topics: Animals; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmaniasis, Visceral; NADH, NADPH Oxidoreductases; Spermidine; Triazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2017 |
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds.
Topics: Animals; Antiparasitic Agents; Cell Line, Tumor; Chalcones; Cyclodextrins; Drug Carriers; Mice; Solubility; Trypanosomatina | 2017 |
Synthesis, in vitro and in vivo giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Drug Design; Female; Giardia lamblia; Giardiasis; Humans; Leishmania; Mice; Nitro Compounds; Protozoan Infections; Thiazoles; Trichomonas vaginalis; Trypanosoma cruzi | 2017 |
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections.
Topics: Antiprotozoal Agents; Chagas Disease; Dose-Response Relationship, Drug; Humans; Macrophages; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Thiosemicarbazones; Trypanosoma | 2018 |
Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
Topics: Antineoplastic Agents; Antiprotozoal Agents; Carbolines; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Leishmania donovani; Leishmania infantum; Molecular Structure; Parasitic Sensitivity Tests; Piperazines; Structure-Activity Relationship | 2018 |
Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Quinoxalines; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi | 2018 |
Nongenotoxic 3-Nitroimidazo[1,2-
Topics: | 2019 |
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
Topics: Animals; Antiprotozoal Agents; Benzothiazoles; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Half-Life; Leishmania major; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Oxidoreductases; Protozoan Proteins; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosomiasis | 2019 |
Indole-Containing Pyrazino[2,1-
Topics: | 2022 |
Pyrimido[5,4-
Topics: | 2022 |
Drug resistance in Indian visceral leishmaniasis.
Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome | 2001 |
Challenges in the management of visceral leishmaniasis.
Topics: Amebicides; Amphotericin B; Antimony Sodium Gluconate; Antiparasitic Agents; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulin G; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine | 2005 |
Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Colorimetry; Drug Evaluation, Preclinical; Humans; Indicators and Reagents; Inhibitory Concentration 50; Kinetics; Leishmania; Leishmania donovani; Leishmaniasis, Visceral; Pentamidine; Phosphorylcholine; Tetrazolium Salts; Thiazoles | 2006 |
Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media, Serum-Free; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Leishmania donovani; Pentamidine; Phosphorylcholine; Sensitivity and Specificity; Sulfhydryl Compounds | 2009 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Topics: Antiprotozoal Agents; Coinfection; HIV Infections; Humans; Immunocompromised Host; Leishmania infantum; Leishmaniasis, Visceral; Pentamidine; Phosphorylcholine | 2016 |
Visceral leishmaniasis in a patient with systemic lupus erythematosus from Colombia, Latin America.
Topics: Adult; Antiprotozoal Agents; Colombia; Humans; Leishmaniasis, Visceral; Lupus Erythematosus, Systemic; Male; Pentamidine; Phosphorylcholine | 2019 |
Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Caspases; Cell Cycle; Cell Line; Cell Membrane; Cell Membrane Permeability; Female; Flow Cytometry; Inhibitory Concentration 50; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Pentamidine; Phospholipids; Phosphorylcholine; Semicarbazones | 2019 |
Anti-leishmanial physalins-Phytochemical investigation, in vitro evaluation against clinical and MIL-resistant L. tropica strains and in silico studies.
Topics: Antiprotozoal Agents; Humans; Leishmania major; Leishmaniasis, Cutaneous; Molecular Docking Simulation; Pentamidine; Phosphorylcholine; Phytochemicals | 2022 |
Comparing cytotoxicity and efficacy of miltefosine and standard antimicrobial agents against Acanthamoeba trophozoites and cyst forms: An in vitro study.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents; Chlorhexidine; Chlorocebus aethiops; Cysts; Humans; Pentamidine; Trophozoites; Vero Cells | 2023 |